BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1233@pharmaconomics
DTSTAMP:20260707T021633Z
DTSTART;VALUE=DATE:20261031
DTEND;VALUE=DATE:20261101
SUMMARY:NSRX Phase 3 — NS002 (estimated date)
DESCRIPTION:Phase 3 trial results for NS002 in anaphylaxis are due ~ Oct 31\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/2029039/000149315226012663/ex99-1.htm\n\nTrack it: https://pharmaconomics.com/e/1233
URL:https://pharmaconomics.com/e/1233
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:NSRX catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR